Looker Benjamin

Insider profile

Performance

Overall performance
3.9

Performance over holding periods
3.9
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 84% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Looker Benjamin's trades of Esperion Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-18 2026-03-17 S Sale
57,956 -34.3%
354.92
US$977,602
57,956 -34.3% 354.92 US$977,602
2026-03-17 2026-03-17 PrS Proposed sale
26,871
157.09
US$225,885
26,871 157.09 US$225,885
2026-01-21 2026-01-20 S Sale
13,242 -30.2%
133.54
US$113,985
13,242 -30.2% 133.54 US$113,985
2026-01-20 2026-01-20 PrS Proposed sale
1,689
2.88
US$4,867
1,689 2.88 US$4,867
2025-12-18 2025-12-17 S Sale
6,517 -1.7%
3.67
US$23,898
6,517 -1.7% 3.67 US$23,898
2025-12-17 2025-12-17 PrS Proposed sale
6,517
3.67
US$23,897
6,517 3.67 US$23,897
2025-10-20 2025-10-17 S Sale
1,248 -0.3%
2.62
US$3,275
1,248 -0.3% 2.62 US$3,275
2025-10-17 2025-10-17 PrS Proposed sale
1,248
2.62
US$3,275
1,248 2.62 US$3,275
2025-09-18 2025-09-17 S Sale
6,267 -1.6%
2.80
US$17,573
6,267 -1.6% 2.80 US$17,573
2025-09-17 2025-09-17 PrS Proposed sale
6,267
2.80
US$17,576
6,267 2.80 US$17,576
2025-07-18 2025-07-17 S Sale
1,304 -0.3%
1.13
US$1,470
1,304 -0.3% 1.13 US$1,470
2025-07-17 2025-07-17 PrS Proposed sale
1,304
1.13
US$1,469
1,304 1.13 US$1,469
2025-06-18 2025-06-17 S Sale
6,422 -1.6%
1.15
US$7,398
6,422 -1.6% 1.15 US$7,398
2025-06-17 2025-06-17 PrS Proposed sale
6,422
1.15
US$7,398
6,422 1.15 US$7,398
2023-04-20 2023-04-19 S Sale
1,290 -1.5%
1.27
US$1,641
1,290 -1.5% 1.27 US$1,641
2023-04-19 2023-04-19 PrS Proposed sale
1,290
1.27
US$1,640
1,290 1.27 US$1,640
2023-01-19 2023-01-18 S Sale
6,347 -9.0%
7.00
US$44,404
6,347 -9.0% 7.00 US$44,404